flow study glp 1 Mapping the effectiveness and risks of GLP-1 receptor agonists Glucagon‐like peptide‐1 therapy in people

At this time, GLP-1s should not be viewed as dementia treatments, but their role in long-term brain health remains an active area of research

It mimics the hormone responsible for sending satiety (satiety) signals to the brain

Naunyn Schmiedeberg Arch Pharmacol 2011;384:93102

Mounjaro achieves approximately 21% body weight loss after one year at the highest dose, compared to about 8% with Rybelsus 14 mg

Managing diabetes, losing excess weight, and improving overall cardiometabolic health are all brain healthy, and if GLP-1 RAs can help with these, shouldnt they be brain healthy as well

Kwong W, Tomlinson G, Feig DS